| IPO Peer Effects C Aghamolla, RT Thakor Journal of Financial Economics 144 (1), 206-226, 2022 | 125 | 2022 |
| Trust in lending RT Thakor, RC Merton The Review of Economics and Statistics, forthcoming, 2024 | 109 | 2024 |
| Competition and R&D Financing: Evidence from the Biopharmaceutical Industry RT Thakor, AW Lo Journal of Financial and Quantitative Analysis 57 (5), 1885-1928, 2022 | 98* | 2022 |
| Customers and Investors: A Framework for Understanding the Evolution of Financial Institutions RC Merton, RT Thakor Journal of Financial Intermediation 39 (July), 4-18, 2019 | 82* | 2019 |
| Just how good an investment is the biopharmaceutical sector? RT Thakor, N Anaya, Y Zhang, C Vilanilam, KW Siah, CH Wong, AW Lo Nature Biotechnology 35 (12), 1149–1157, 2017 | 79* | 2017 |
| Do mandatory disclosure requirements for private firms increase the propensity of going public? C Aghamolla, RT Thakor Journal of Accounting Research 60 (3), 755-804, 2022 | 73 | 2022 |
| Find and Replace: R&D Investment Following the Erosion of Existing Products J Krieger, X Li, RT Thakor Management Science 68 (9), 6355-7064, 2022 | 49 | 2022 |
| The effect of cash injections: Evidence from the 1980s farm debt crisis NK Bergman, R Iyer, RT Thakor The Review of Financial Studies 33 (11), 5092-5130, 2020 | 42 | 2020 |
| Financing biomedical innovation AW Lo, RT Thakor Annual Review of Financial Economics 14 (1), 231-270, 2022 | 36* | 2022 |
| Short-termism, Managerial Talent, and Firm Value RT Thakor The Review of Corporate Finance Studies 10 (3), 473-512, 2021 | 36* | 2021 |
| Merchants of death: The effect of credit supply shocks on hospital outcomes C Aghamolla, P Karaca-Mandic, X Li, RT Thakor American Economic Review 114 (11), 3623-3668, 2024 | 30 | 2024 |
| Sharing R&D risk in healthcare via FDA hedges A Jørring, AW Lo, TJ Philipson, M Singh, RT Thakor The Review of Corporate Finance Studies 11 (4), 880-922, 2022 | 29 | 2022 |
| Financial Intermediation and the Funding of Biomedical Innovation: A Review AW Lo, RT Thakor Journal of Financial Intermediation 54 (April), 2023 | 27 | 2023 |
| Optimal Financing Design for Drug Development Firms RT Thakor, AW Lo Research Policy, forthcoming, 2024 | 26* | 2024 |
| Paying off the competition: Market power and innovation incentives X Li, AW Lo, RT Thakor National Bureau of Economic Research, 2021 | 22 | 2021 |
| Trust, Transparency, and Complexity RT Thakor, RC Merton The Review of Financial Studies 36 (8), 3213-3256, 2023 | 18 | 2023 |
| Liquidity windfalls and reallocation: Evidence from farming and fracking RT Thakor Management Science 69 (10), 6224-6250, 2023 | 15* | 2023 |
| Appropriated growth Y Chen, X Li, RT Thakor, C Ward Available at SSRN 4244951, 2024 | 13 | 2024 |
| Proposing an innovative bond to increase investments in social drivers of health interventions in Medicaid managed care P Karaca-Mandic, S Nikpay, S Gibbons, D Haynes, R Koranne, RT Thakor Health Affairs 42 (3), 383-91, 2023 | 11 | 2023 |
| No-fault Default, Chapter 11 Bankruptcy, and Financial Institutions RC Merton, RT Thakor Journal of Banking & Finance 140, 2022 | 11 | 2022 |
Cyrus AghamollaRice University確認したメール アドレス: umn.edu
